2 Comments

It's nice to (finally) see another investor interested in this company! The interest on e.g. Twitter is so nonexistent that I always wonder if I'm the idiot in the room for liking the company.

To me their strategy (real estate purchases, automation) make total sense! What I'd like to understand better is their runway outside food/pharma testing (because I don't see their business 10x in those areas).

Expand full comment

Thanks for your comment. The business saw a lot of additional temporary sales during COVID, and the market became overly enthusiastic in its valuation. After COVID, sales returned to a normal level, and the market penalized its valuation.

But Gilles Martin is taking advantage of all that extra income to invest heavily (creating a large global infrastructure network, buying real estate where he has a clear vision that will be important in the future, making acquisitions of many startups with large growth in niche sectors although right now they are not giving positive profitability,....). All this represents a lot of investment that is not yet providing returns, but it will.

So we patient investors have to wait. How long? Maybe 2-3 years, but at least we can see how accounting does what the CEO says. For this reason, I recommend reading or listening to Gilles Martin's results presentations, as they will provide you with a lot of value.

Expand full comment